International Journal of Molecular Sciences (Mar 2023)

Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder

  • Manuela Loi,
  • Stefano Bastianini,
  • Giulia Candini,
  • Nicola Rizzardi,
  • Giorgio Medici,
  • Valentina Papa,
  • Laura Gennaccaro,
  • Nicola Mottolese,
  • Marianna Tassinari,
  • Beatrice Uguagliati,
  • Chiara Berteotti,
  • Viviana Lo Martire,
  • Giovanna Zoccoli,
  • Giovanna Cenacchi,
  • Stefania Trazzi,
  • Christian Bergamini,
  • Elisabetta Ciani

DOI
https://doi.org/10.3390/ijms24065552
Journal volume & issue
Vol. 24, no. 6
p. 5552

Abstract

Read online

CDKL5 (cyclin-dependent kinase-like 5) deficiency disorder (CDD) is a severe neurodevelopmental disease that mostly affects girls, who are heterozygous for mutations in the X-linked CDKL5 gene. Mutations in the CDKL5 gene lead to a lack of CDKL5 protein expression or function and cause numerous clinical features, including early-onset seizures, marked hypotonia, autistic features, gastrointestinal problems, and severe neurodevelopmental impairment. Mouse models of CDD recapitulate several aspects of CDD symptomology, including cognitive impairments, motor deficits, and autistic-like features, and have been useful to dissect the role of CDKL5 in brain development and function. However, our current knowledge of the function of CDKL5 in other organs/tissues besides the brain is still quite limited, reducing the possibility of broad-spectrum interventions. Here, for the first time, we report the presence of cardiac function/structure alterations in heterozygous Cdkl5 +/− female mice. We found a prolonged QT interval (corrected for the heart rate, QTc) and increased heart rate in Cdkl5 +/− mice. These changes correlate with a marked decrease in parasympathetic activity to the heart and in the expression of the Scn5a and Hcn4 voltage-gated channels. Interestingly, Cdkl5 +/− hearts showed increased fibrosis, altered gap junction organization and connexin-43 expression, mitochondrial dysfunction, and increased ROS production. Together, these findings not only contribute to our understanding of the role of CDKL5 in heart structure/function but also document a novel preclinical phenotype for future therapeutic investigation.

Keywords